Steve Gavel insider trades
Open-market stock purchases and sales by Steve Gavel, Chief Commercial Officer at Cabaletta Bio, Inc, from SEC Form 4 filings since Oct 13, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +43%.
Companies traded
- CABA Cabaletta Bio, Inc: 1 buy, last Jan 21, 2026